NEW YORK (GenomeWeb News) – Cepheid is asking a federal court to declare two patents held by Roche invalid.

In a lawsuit filed last week in the US District Court for the Northern District of California, Cepheid asked the court also to find that it does not infringe US Patent Nos. 5,804,375 and 6,127,155 held by Roche.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.